In the U.S., 64,000 new cases of type 1 diabetes are diagnosed annually, and non-Hispanic white people are more likely to develop T1D than Black and Hispanic people, according to JDRF, a nonprofit that funds TID research.
JDRF Celebrates Tzield™ (teplizumab-mzwv) Approval streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
FRIDAY, Nov. 18, 2022 (HealthDay News) The U.S. Food and Drug Administration on Thursday approved the first drug that could delay the development of type 1 diabetes (T1D).